Nyxoah S. A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.